Under explored epigenetic modulators: role in glioma chemotherapy

Multidimensional Evaluation of the Quality of Rural Life Using Big Data from the Perspective of Common Prosperity

Evaluating and revealing the spatial differentiations of quality of rural life (QRL) is the basis for formulating rural revitalization planning to promote rural transformation and achieve common prosperity. Taking the Lin'an District of Hangzhou city in China, an economically developed mountainous area, as an example, this study explored the connotation of QRL from the perspective of common prosperity and constructed a QRL evaluation framework involving living, employment, consumption, and leisure aspects. Then, based on multi-sourced data of 270 administrative villages as the assessment unit, we revealed the spatial patterns of QRL and proposed optimization paths to improving QRL. The results showed that (1) differences in the spatial distribution of quality of rural living, employment, consumption, and leisure of Lin'an District were significant, presenting stepped, block clustering, irregularity, and scattered patterns, respectively. (2) The overall QRL was mainly at a low level, clustered spatially, distributed in a strip pattern, and with obvious road directionality. (3) Based on the evaluation results of QRL, we divided the 270 administrative villages into six types of improvement: livability, employment, consumption, leisure, and balanced and lagged development types. This study could provide a scientific cognitive basis for the improvement of QRL and a useful reference for rural revitalization in China.

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective

Glioblastoma multiforme (GBM) is the most common tumor of the CNS, and the deadliest form of brain cancer. The rapid progression, the anatomic location in the brain and a deficient knowledge of the pathophysiology, often limit the effectiveness of therapeutic interventions. Current pillars of GBM therapies include surgical resection, radiotherapy and chemotherapy, but the low survival rate and the short life expectation following these treatments strongly underline the urgency to identify innovative and more effective therapeutic tools. Frequently, patients subjected to a mono-target therapy, such as Temozolomide (TMZ), develop drug resistance and undergo relapse, indicating that targeting a single cellular node is not sufficient for eradication of this disease. In this context, a multi-targeted therapeutic approach aimed at using compounds, alone or in combination, capable of inhibiting more than one specific molecular target, offers a promising alternative. Such strategies have already been well integrated into drug discovery campaigns, including in the field of anticancer drugs. In this miniperspective, we will discuss the recent progress in the treatment of GBM focusing on innovative and effective preclinical strategies, which are based on a multi-targeted approach.